Last reviewed · How we verify
NCT07326670: PCNL-ANES-INF
Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL
trial in Anesthesia Techniques in 90 participants. Currently enrolling.
15 February 2026
Quick facts
| Lead sponsor | Elazıg Fethi Sekin Sehir Hastanesi |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 15 October 2025 |
| Primary completion | 15 February 2026 |
| Estimated completion | 15 April 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Anesthesia Techniques — all drugs for Anesthesia Techniques →
- Percutaneous Nephrolithotomy — all drugs for Percutaneous Nephrolithotomy →
- Systemic Inflammation — all drugs for Systemic Inflammation →
Sponsor
Elazıg Fethi Sekin Sehir Hastanesi — full company profile →
Who can join
18 and older, any sex, with Anesthesia Techniques or Percutaneous Nephrolithotomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study aims to compare the effects of spinal and general anesthesia on perioperative systemic inflammatory response in patients undergoing percutaneous nephrolithotomy (PCNL). Systemic inflammatory indices derived from routine complete blood count parameters, including Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Aggregate Index of Systemic Inflammation (AISI), Neutrophil-to-Lymphocyte Ratio (NLR), and Red Cell Distribution Width (RDW), will be evaluated. Preoperative and postoperative laboratory values will be analyzed to determine whether the type of anesthesia influences systemic inflammatory markers and related clinical outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07326670
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Elazıg Fethi Sekin Sehir Hastanesi trials
Trials by the same sponsor.
- NCT07435896 — Impact of Information and Participation on Decision Time for Tracheostomy or PEG in ICU Families · not yet recruiting
- NCT07480720 — Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease · recruiting
- NCT07437443 — Burnout, Secondary Traumatic Stress and Inflammatory Biomarkers in ICU Healthcare Workers · not yet recruiting
- NCT07434362 — Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy · NA · completed
- NCT07415928 — Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07326670 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elazıg Fethi Sekin Sehir Hastanesi
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07326670.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing